ICYMI: UK Paying Less for Cancer Drugs Than Other EU Countries

According to Pharmatimes.com, “The UK is paying less for new cancer drugs than most other countries in Europe, a new report has found.  The study in The Lancet Oncology also reveals that the prices of such drugs vary widely – from 28 percent to 388 percent –...

Eli Lilly Reports Medication Slows Alzheimer’s Decline

According to an article via South Bend Tribune, “Eli Lilly & Co. reported Wednesday that an experimental medication might slow mild Alzheimer’s if people take it early enough, one of a handful of drugs in late-stage testing in the frustrating hunt for a...

There is No Such Thing as “Low Hanging Fruit” in Drug R&D

Forbes just posted this thought-provoking article written by the former President of Pfizer Global Research.  Using an approach Merck attempted as an example, he discusses some of the challenges that decision makers face these days in relation to drug safety,...